• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

脓毒症性心肌病的现状：基础科学与临床进展

Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.

作者信息

Lin Huan, Wang Wenting, Lee Madeline, Meng Qinghe, Ren Hongsheng

机构信息

Department of Intensive Care Unit, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.

Dartmouth College, Hanover, NH, United States.

出版信息

Front Pharmacol. 2020 Mar 3;11:210. doi: 10.3389/fphar.2020.00210. eCollection 2020.

DOI:10.3389/fphar.2020.00210
PMID:32194424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7062914/
Abstract

Septic cardiomyopathy (SCM) is a complication that is sepsis-associated cardiovascular failure. In the last few decades, there is progress in diagnosis and treatment despite the lack of consistent diagnostic criteria. According to current studies, several hypotheses about pathogenic mechanisms have been revealed to elucidate the pathophysiological characteristics of SCM. The objective of this manuscript is to review literature from the past 5 years to provide an overview of current knowledge on pathogenesis, diagnosis and treatment in SCM.

摘要

脓毒症性心肌病（SCM）是一种与脓毒症相关的心血管功能衰竭并发症。在过去几十年中，尽管缺乏一致的诊断标准，但在诊断和治疗方面仍取得了进展。根据目前的研究，已经揭示了几种关于致病机制的假说，以阐明SCM的病理生理特征。本手稿的目的是回顾过去5年的文献，以概述目前关于SCM发病机制、诊断和治疗的知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/7062914/686262f3695f/fphar-11-00210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/7062914/3910825b0c64/fphar-11-00210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/7062914/686262f3695f/fphar-11-00210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/7062914/3910825b0c64/fphar-11-00210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/7062914/686262f3695f/fphar-11-00210-g002.jpg

相似文献

1
Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.脓毒症性心肌病的现状：基础科学与临床进展
Front Pharmacol. 2020 Mar 3;11:210. doi: 10.3389/fphar.2020.00210. eCollection 2020.
2
The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.脓毒症性心脏病：分子机制的现有认识及临床意义。
Chest. 2019 Feb;155(2):427-437. doi: 10.1016/j.chest.2018.08.1037. Epub 2018 Aug 29.
3
Progress of heparanase in septic cardiomyopathy: A review.肝素酶在脓毒症性心肌病中的研究进展：综述。
Medicine (Baltimore). 2024 Aug 16;103(33):e38901. doi: 10.1097/MD.0000000000038901.
4
[Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].[脓毒症中的心脏：脓毒性心肌病的分子机制、诊断与治疗]
Anaesthesist. 2017 Jul;66(7):479-490. doi: 10.1007/s00101-017-0329-x.
5
Mitochondrial Mechanisms in Septic Cardiomyopathy.脓毒症性心肌病中的线粒体机制
Int J Mol Sci. 2015 Aug 3;16(8):17763-78. doi: 10.3390/ijms160817763.
6
Dysregulated autophagy-related genes in septic cardiomyopathy: Comprehensive bioinformatics analysis based on the human transcriptomes and experimental validation.脓毒症性心肌病中自噬相关基因的失调：基于人类转录组的综合生物信息学分析及实验验证
Front Cardiovasc Med. 2022 Aug 2;9:923066. doi: 10.3389/fcvm.2022.923066. eCollection 2022.
7
The peripheral blood transcriptome in septic cardiomyopathy: an observational, pilot study.脓毒症性心肌病的外周血转录组：一项观察性试点研究。
Intensive Care Med Exp. 2019 Oct 24;7(1):57. doi: 10.1186/s40635-019-0271-0.
8
A review of sepsis-induced cardiomyopathy.脓毒症相关性心肌病研究综述
J Intensive Care. 2015 Nov 11;3:48. doi: 10.1186/s40560-015-0112-5. eCollection 2015.
9
Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.脓毒症心肌病中的线粒体损伤与靶向干预。
Curr Pharm Des. 2019;25(18):2060-2070. doi: 10.2174/1381612825666190708155400.
10
Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature.脓毒症性心肌病的病理生理学、超声心动图评估、生物标志物研究结果及预后意义：文献复习。
Crit Care. 2018 May 4;22(1):112. doi: 10.1186/s13054-018-2043-8.

引用本文的文献

1
Predictive value of combined inflammatory markers for septic cardiomyopathy: a retrospective study.联合炎症标志物对脓毒症性心肌病的预测价值：一项回顾性研究
BMC Infect Dis. 2025 Aug 18;25(1):1033. doi: 10.1186/s12879-025-11447-8.
2
The Role of Protein Ubiquitination in the Onset and Progression of Sepsis.蛋白质泛素化在脓毒症发生发展中的作用
Cells. 2025 Jul 2;14(13):1012. doi: 10.3390/cells14131012.
3
c-FLIP Protects Cardiac Microcirculation in Sepsis-Induced Myocardial Dysfunction Via FUNDC1-Mediated Regulation of Mitochondrial Autophagy.

本文引用的文献

1
Elevated Plasma Histone H4 Levels Are an Important Risk Factor in the Development of Septic Cardiomyopathy.血浆组蛋白 H4 水平升高是导致脓毒性心肌病的一个重要危险因素。
Balkan Med J. 2020 Feb 28;37(2):72-78. doi: 10.4274/balkanmedj.galenos.2019.2019.8.40. Epub 2019 Nov 1.
2
Sepsis roadmap: What we know, what we learned, and where we are going.脓毒症路线图：我们知道什么，我们学到了什么，我们要去哪里。
Clin Immunol. 2020 Jan;210:108264. doi: 10.1016/j.clim.2019.108264. Epub 2019 Oct 23.
3
The peripheral blood transcriptome in septic cardiomyopathy: an observational, pilot study.
c-FLIP通过FUNDC1介导的线粒体自噬调节保护脓毒症诱导的心肌功能障碍中的心脏微循环。
JACC Basic Transl Sci. 2025 Aug;10(8):101257. doi: 10.1016/j.jacbts.2025.02.016. Epub 2025 May 14.
4
Roles and Therapeutic Targeting of Exosomes in Sepsis-Induced Cardiomyopathy.外泌体在脓毒症诱导的心肌病中的作用及治疗靶点
J Cell Mol Med. 2025 Apr;29(8):e70559. doi: 10.1111/jcmm.70559.
5
Exploring the pathogenesis of sepsis-induced cardiomyopathy: Multilayered mechanisms and clinical responses.探索脓毒症诱导性心肌病的发病机制：多层机制与临床反应
Sci Prog. 2025 Jan-Mar;108(1):368504251329190. doi: 10.1177/00368504251329190. Epub 2025 Mar 20.
6
Monotropein inhibits MMP9-mediated cardiac oxidative stress, inflammation, matrix degradation and apoptosis in a mouse and cell line models of septic cardiac injury.水晶兰苷在脓毒症性心脏损伤的小鼠和细胞系模型中抑制MMP9介导的心脏氧化应激、炎症、基质降解和细胞凋亡。
Mol Biol Rep. 2025 Mar 20;52(1):329. doi: 10.1007/s11033-025-10421-6.
7
Prognostic analysis of sepsis-induced myocardial injury patients using propensity score matching and doubly robust analysis with machine learning-based risk prediction model development.使用倾向评分匹配和双重稳健分析以及基于机器学习的风险预测模型开发对脓毒症诱导的心肌损伤患者进行预后分析。
Front Med (Lausanne). 2025 Feb 19;12:1555103. doi: 10.3389/fmed.2025.1555103. eCollection 2025.
8
Role and Mechanism of Mitochondrial Ribosomal Proteins in Septic Myocardial Injury.线粒体核糖体蛋白在脓毒症性心肌损伤中的作用及机制
J Inflamm Res. 2025 Feb 21;18:2677-2698. doi: 10.2147/JIR.S495987. eCollection 2025.
9
Targeting Lcn2 to Inhibit Myocardial Cell Ferroptosis is a Potential Therapy for Alleviating Septic Cardiomyopathy.靶向Lipocalin-2抑制心肌细胞铁死亡是缓解脓毒症心肌病的一种潜在治疗方法。
Inflammation. 2025 Feb 3. doi: 10.1007/s10753-025-02250-3.
10
Cardiac-specific ITCH overexpression ameliorates septic cardiomyopathy inhibition of the NF-κB signaling pathway.心脏特异性ITCH过表达通过抑制NF-κB信号通路改善脓毒症心肌病。
J Mol Cell Cardiol Plus. 2022 Nov 2;2:100018. doi: 10.1016/j.jmccpl.2022.100018. eCollection 2022 Dec.
脓毒症性心肌病的外周血转录组：一项观察性试点研究。
Intensive Care Med Exp. 2019 Oct 24;7(1):57. doi: 10.1186/s40635-019-0271-0.
4
Mediates Mitochondrial Dysfunction in Septic Cardiomyopathy.介导脓毒症心肌病中的线粒体功能障碍。
DNA Cell Biol. 2019 Nov;38(11):1197-1206. doi: 10.1089/dna.2019.4839. Epub 2019 Oct 16.
5
Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway.褪黑素减轻脓毒症性心肌病中的内质网应激和线粒体损伤：涉及 BAP31 上调和 MAPK-ERK 通路的新机制。
J Cell Physiol. 2020 Mar;235(3):2847-2856. doi: 10.1002/jcp.29190. Epub 2019 Sep 18.
6
Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.细胞吸附疗法在感染性休克 ICU 患者中观察到的 28 天全因死亡率低于预期：一项倾向评分加权回顾性研究。
Crit Care. 2019 Sep 18;23(1):317. doi: 10.1186/s13054-019-2588-1.
7
The Challenging Diagnosis of Septic Cardiomyopathy.感染性心肌病的诊断难题
Chest. 2019 Sep;156(3):635-636. doi: 10.1016/j.chest.2019.04.136.
8
H Protects Against Lipopolysaccharide-Induced Cardiac Dysfunction Blocking TLR4-Mediated Cytokines Expression.H 通过阻断 TLR4 介导的细胞因子表达来预防脂多糖诱导的心脏功能障碍。
Front Pharmacol. 2019 Aug 5;10:865. doi: 10.3389/fphar.2019.00865. eCollection 2019.
9
Identification of Biomarkers Associated with Septic Cardiomyopathy Based on Bioinformatics Analyses.基于生物信息学分析鉴定脓毒性心肌病相关的生物标志物。
J Comput Biol. 2020 Jan;27(1):69-80. doi: 10.1089/cmb.2019.0181. Epub 2019 Aug 19.
10
Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: A novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function.褪黑素对脓毒症性心肌病治疗作用的研究进展：一个联系 Ripk3 修饰的线粒体功能和内质网功能的新机制。
Redox Biol. 2019 Sep;26:101287. doi: 10.1016/j.redox.2019.101287. Epub 2019 Jul 27.